Myriad Genetics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
MYGN Nasdaq 2834 19.52 Stock Down -0.18

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Myriad Genetics, Inc.

7:06 am Myriad Genetics announces that it will work with Sanofi (SNY) to perform a biomarker analysis of blood samples from the Evaluation of Lixisenatide in Acute Coronary Syndrome trial - Oct 25th, 2016 5:06 am